CXCR4 and neoplasm: Finally, considering the aforementioned role of MAD2 in tumorigenesis, we hypothesize that GCSCs from tumors with high levels of MAD2 have an activated CXCR4-SNAI2 signalling pathway, increasing the expression of MMP1, which translates into higher invasion and tumor growth.